Wednesday, July 6, 2016 5:02:00 AM PDT | VentureDeal
Langhorne, Pennsylvania -- Biopharmaceutical technology company Aprecia Pharmaceuticals has received a commitment for up to $30 million in venture capital debt investment.
Aprecia has created a delivery platform called ZipDose that utilizes its proprietary three-dimensional printing system. "It creates premeasured, spill-proof unit doses designed to disintegrate in the mouth with just a sip of liquid." Hercules Capital made the commitment, which has already funded $20 million. The remaining $10 million may be drawn upon achievement of a certain performance milestone.
Email Page | Print Page
Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?
Start your Free 14 Day Trial now – no obligation or credit card required.
